SMTL ID : 6xk4.1

Nitric Oxide Synthase from Bacillus subtilis in complex with 7-((3-(((3-(6-aminopyridin-2-yl)propyl)amino)methyl)phenoxy)methyl)quinolin-2-amine

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.13 Å

Oligo State

homo-dimer

Ligands

2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 18 residues within 4Å: Chain A: W.60, S.63, R.65, C.66, I.67, M.221, F.235, N.236, G.237, W.238, M.240, E.243, V.300, W.329, Y.355, Y.357 Ligands: V5D.2, GOL.4 17 PLIP interactions: 17 interactions with chain A, Hydrophobic interactions: A:W.60, A:W.60, A:W.60, A:R.65, A:I.67, A:F.235, A:F.235, A:F.235, A:W.238, A:E.243, A:V.300, A:Y.355 Water bridges: A:R.247, A:W.329 Salt bridges: A:R.65 pi-Stacking: A:W.60 Metal complexes: A:C.66 HEM.5: 18 residues within 4Å: Chain B: W.60, S.63, R.65, C.66, I.67, M.221, F.235, N.236, G.237, W.238, M.240, E.243, V.300, W.329, Y.355, Y.357 Ligands: V5D.6, GOL.8 17 PLIP interactions: 17 interactions with chain B, Hydrophobic interactions: B:W.60, B:W.60, B:W.60, B:R.65, B:I.67, B:F.235, B:F.235, B:F.235, B:W.238, B:E.243, B:V.300, B:Y.355 Water bridges: B:R.247, B:W.329 Salt bridges: B:R.65 pi-Stacking: B:W.60 Metal complexes: B:C.66

2 x V5D: 7-{[3-({[4-(6-aminopyridin-2-yl)butyl]amino}methyl)phenoxy]methyl}quinolin-2-amine(Non-covalent)

V5D.2: 14 residues within 4Å: Chain A: H.128, P.216, I.218, G.237, W.238, Y.239, E.243, R.247, T.328, W.329, Y.357 Chain B: W.327, F.342 Ligands: HEM.1 8 PLIP interactions: 5 interactions with chain A, 3 interactions with chain B Hydrophobic interactions: A:I.218, B:W.327, B:F.342 Hydrogen bonds: A:M.240, A:E.243, B:W.327 pi-Stacking: A:W.329, A:W.329 V5D.6: 14 residues within 4Å: Chain A: W.327, F.342 Chain B: H.128, P.216, I.218, G.237, W.238, Y.239, E.243, R.247, T.328, W.329, Y.357 Ligands: HEM.5 8 PLIP interactions: 3 interactions with chain A, 5 interactions with chain B Hydrophobic interactions: A:W.327, A:F.342, B:I.218 Hydrogen bonds: A:W.327, B:M.240, B:E.243 pi-Stacking: B:W.329, B:W.329

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 4 residues within 4Å: Chain A: Q.129, Y.213, Y.239, N.248 Ligand excluded by PLIP CL.7: 4 residues within 4Å: Chain B: Q.129, Y.213, Y.239, N.248 Ligand excluded by PLIP

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.4: 6 residues within 4Å: Chain A: M.221, I.350, Y.355, F.356, Y.357 Ligands: HEM.1 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:Y.355, A:Y.357 Water bridges: A:R.65, A:N.348 GOL.8: 6 residues within 4Å: Chain B: M.221, I.350, Y.355, F.356, Y.357 Ligands: HEM.5 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:Y.355, B:Y.357 Water bridges: B:R.65, B:N.348

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lewis, M.C. et al., Selective Anti-MRSA inhibitors targeting Nitric Oxide Synthase. To Be Published

Release Date

2021-06-30

Peptides

Nitric oxide synthase oxygenase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Nitric oxide synthase oxygenase

Related Entries With Identical Sequence